C ardiovascular disease is the leading cause of death among men and women in developed countries. 1 Most of this premature mortality occurs in a subgroup of the population that is prone to accelerated atherogenesis caused by genetic, lifestyle, and environmental factors, along with their interactions. Growing evidence suggests that vitamin D deficiency is associated with coronary artery disease (CAD) development. 2 However, mechanistic evidence supporting this association is lacking. Coronary artery calcification (CAC) is strongly associated with risk of vascular disease, 3, 4 and several studies report an inverse relationship between levels of the active form of vitamin D and atherosclerotic calcification. 5 Therefore, it is important to understand if vitamin D metabolism influences degree of CAC; insights into this relationship would provide support for a role of vitamin D in the pathogenesis of CAD.
See accompanying article on page 2648
In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Shen et al 6 present a well-designed candidate gene study to investigate the association of single-nucleotide polymorphisms (SNPs) in key genes involved in vitamin D metabolism with CAC. The CAC phenotype was quantified as the sum of the calcification scores in both left and right coronary arteries. The researchers selected 5 genes, cytochrome P450, family 2, subfamily R (CYP2R1), cytochrome P450, family 27, subfamily B (CYP27B1), cytochrome P450, family 24, subfamily A (CYP24A1), vitamin D receptor (VDR), Viatmin D-binding protein (GC), known to be involved in vitamin D homeostasis. 6 -8 In the discovery phase, they conducted the association analysis in samples from Amish families (Nϭ697), with 39 genotyped SNPs from 4 available genes using a chip (HumanCVD BeadChip V2). Although no SNPs in the CYP27B1, VDR, or GC genes were associated with CAC score, 4 SNPs in the CYP24A1 gene were nominally associated with CAC score (Pϭ0.008 to Pϭ0.00003) in the discovery phase. Then, these 4 SNPs were tested for replication in samples from the Genetic Epidemiology Network of Arteriopathy (Nϭ916) and the Penn Coronary Artery Calcification (Nϭ2061), 2 independent cohorts of European white ancestry (Figure) . In the replication phase, 1 of these 4 SNPs, rs2762939, demonstrated evidence of an association with CAC in both the Genetic Epidemiology Network of Arteriopathy and the Penn Coronary Artery Calcification cohorts (Pϭ0.01 and Pϭ0.007, respectively). The subsequent meta-analysis of the data from these 3 populations yielded a probability value of 2.9ϫ10 more, it will be worthwhile to investigate whether this SNP affects the transcription and protein product levels of the genes involved in the maintenance of 1,25(OH) 2 D and 25(OH)D levels.
This finding raises interesting questions about the direct role of vitamin D in the progression or initiation of atherosclerosis. Other research has discovered that vitamin D lowers the activity of the inflammatory activator nuclear factor B, inhibiting foam cell formation and suppressing macrophage cholesterol uptake in patients with type 2 diabetes mellitus. 11, 12 On the other hand, vitamin D levels are correlated with other CAD risk factors, such as hypertension, hyperlipidemia, and diabetes. [13] [14] [15] [16] [17] Therefore, the described association may occur directly through vitamin D metabolism or indirectly through other pathways, regardless of their effect on 25(OH)D, by influencing known risk factors for cardiovascular disease (ie, hypertension, diabetes, and inflammation).
This study suggests a role for vitamin D homeostasis in CAC and provides an important signpost on the road toward understanding the role of calcium and vitamin D metabolism in risk of CAD.
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